首页> 美国卫生研究院文献>Neuro-Oncology >NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT

【2h】

NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT

机译：nimg-03。预期期II型随机试验比较质子疗法与Photon IMRT for GBM：RANO与RANO之间的进展免费生存的二次分析比较临床和放射学评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To compare tumor progression based on clinical radiological assessment and on Response Assessment in Neuro-Oncology (RANO) criteria between GBM patients treated with proton radiotherapy (PT) vs. photon intensity modulated radiotherapy (IMRT).

机译：基于临床放射学评估的肿瘤进展与神经肿瘤学（RANO）响应评估（RANO）患者在质子放射疗法（PT）对照治疗中的临床放射学评估（RANO）标准对光子强度调制放射治疗（IMRT）。

著录项

期刊名称 Neuro-Oncology
作者
Karine Al Feghali; James Randall; Jeffrey Wefel; Nandita Guha-Thakurta; David Grosshans; Seyedeh Dibaj; Sarah McAvoy; Jing Li; Susan McGovern; Mary McAleer; Amol Ghia; Arnold Paulino; Erik Sulman; Marta Penas-Prado; Jihong Wang; John DeGroot; Amy Heimberger; Terri Armstrong; Mark Gilbert; Anita Mahajan; Paul Brown; Caroline Chung;
展开▼
作者单位

展开▼
年(卷),期 2019(21),Suppl 6
年度 2019
页码 vi161–vi162
总页数 2
原文格式 PDF
正文语种
中图分类神经病学;肿瘤学;
关键词

相似文献

外文文献

1. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO) [J] . Al Feghali K. A., Randall J. W., Wefel J. S., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：预期第II期随机试验比较质子疗法对新诊断的GBM：临床放射性评估与临床放射性评估之间进展比较的二次分析比较。临床放射性评估与神经肿瘤学中的反应评估（RANO）
2. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. [J] . Chan AT, Teo PM, Ngan RK, Journal of Clinical Oncology . 2002,第8期

机译：在局部晚期鼻咽癌中同时进行放疗与单独放疗相比：III期随机试验的无进展生存分析。
3. Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial. [J] . Hamberg P, Bos MM, Braun HJ, Clinical breast cancer . 2011,第2期

机译：II期随机研究比较了曲妥珠单抗和多西他赛联合治疗与序贯治疗的曲妥珠单抗联合多西他赛在HER2 +转移性乳腺癌患者一线化疗中的疗效和安全性：HERTAX试验。
4. A comparison of methods for estimating survival probabilities in two stage phase III randomized clinical trials. [D] . Wang, Ying. 2009

机译：在两个阶段的III期随机临床试验中比较评估生存概率的方法。
5. RTHP-18. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR NEWLY DIAGNOSED GBM: SECONDARY ANALYSIS COMPARISON OF GENDER AND NEUTROPHIL-LYMPHOCYTE RATIO (NLR) IN GBM OUTCOMES [O] . James Randall, Karine Al Feghali, Jeffrey Wefel, 2019

机译：RTHP-18。预期期II型随机试验比较质子疗法与用于新诊断的GBM的光子IMRT：GBM结果中性别和中性粒细胞淋巴细胞比（NLR）的二次分析比较
6. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO) [O] . K.A. Al Feghali, J.W. Randall, J.S. Wefel, 2019

机译：预期第II期随机试验比较质子疗法对新诊断的GBM：临床放射性评估与临床放射性评估之间进展比较的二次分析比较。临床放射性评估与神经肿瘤学响应评估

NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT

摘要

著录项

相似文献

相关主题

期刊订阅